Literature DB >> 24474067

Agreement between FRAX scores calculated with and without bone mineral density in women with osteopenia in Turkey.

Nese Olmez Sarikaya1, Secil Kapar Yavasi, Gulten Tan, Servet Satiroglu, Arife Hilal Yildiz, Bengi Oz, Ozlem Yoleri, Asuman Memis.   

Abstract

This study aimed to analyze the agreement between FRAX scores calculated with and without femoral neck (FN) bone mineral density (BMD) and to investigate the resultant treatment recommendations in women with osteopenia. A cross-sectional review of postmenopausal women who were referred for DXA evaluation was conducted. One hundred twenty-nine postmenopausal women aged 40 years and older with osteopenia [FN T-score between -1 and (-2.5)] were recruited for the study. Absolute agreement between FRAX scores calculated with and without BMD was analyzed by intraclass correlation analysis (ICC). Thresholds recommended by National Osteoporosis Foundation were used for treatment recommendations. Correlation between demographic factors and the difference in BMD+ and BMD- FRAX scores was analyzed by Spearman correlation test. Agreement levels and treatment recommendations were also analyzed in 112/129 patients without previous fracture. Agreement between BMD+ and BMD- MO and hip FRAX scores was good (ICC 0.867) and fair to good (ICC 0.641), respectively. In patients without previous fracture, agreement between MO and hip fracture probabilities was good (ICC = 0.838 and ICC = 0.778, respectively). Treatment recommendations with respect to treatment threshold of ≥3 for hip fracture probabilities were identical in 120/129 (93 %) cases. Difference between BMD+ and BMD- fracture probabilities was correlated with age and FN BMD. In most cases, FRAX without BMD provided the same treatment recommendations as FRAX with BMD in postmenopausal women with osteopenia. Exclusion of patients with previous fracture yielded better agreement levels.

Entities:  

Mesh:

Year:  2014        PMID: 24474067     DOI: 10.1007/s10067-014-2491-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

Review 1.  Assessment of fracture risk.

Authors:  John A Kanis; Frederik Borgstrom; Chris De Laet; Helena Johansson; Olof Johnell; Bengt Jonsson; Anders Oden; Niklas Zethraeus; Bruce Pfleger; Nikolai Khaltaev
Journal:  Osteoporos Int       Date:  2004-12-23       Impact factor: 4.507

2.  Frax prediction without BMD for assessment of osteoporotic fracture risk.

Authors:  Ramesh Keerthi Gadam; Karen Schlauch; Kenneth E Izuora
Journal:  Endocr Pract       Date:  2013 Sep-Oct       Impact factor: 3.443

3.  Hip fracture in women without osteoporosis.

Authors:  Stacey A Wainwright; Lynn M Marshall; Kristine E Ensrud; Jane A Cauley; Dennis M Black; Teresa A Hillier; Marc C Hochberg; Molly T Vogt; Eric S Orwoll
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

Review 4.  FRAX(®) with and without bone mineral density.

Authors:  John A Kanis; Eugene McCloskey; Helena Johansson; Anders Oden; William D Leslie
Journal:  Calcif Tissue Int       Date:  2011-11-06       Impact factor: 4.333

5.  Fracture risk assessment without bone density measurement in routine clinical practice.

Authors:  W D Leslie; S Morin; L M Lix; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2011-08-18       Impact factor: 4.507

Review 6.  Osteoporosis update from the 2010 santa fe bone symposium.

Authors:  E Michael Lewiecki; John P Bilezikian; Sundeep Khosla; Robert Marcus; Michael R McClung; Paul D Miller; Nelson B Watts; Michael Maricic
Journal:  J Clin Densitom       Date:  2011 Jan-Mar       Impact factor: 2.617

7.  The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study.

Authors:  Sansin Tuzun; Nurten Eskiyurt; Ulku Akarirmak; Merih Saridogan; Helena Johansson; Eugene McCloskey; John A Kanis
Journal:  Arch Osteoporos       Date:  2012       Impact factor: 2.617

8.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

9.  International variations in hip fracture probabilities: implications for risk assessment.

Authors:  John A Kanis; Olof Johnell; Chris De Laet; Bengt Jonsson; Anders Oden; Alan K Ogelsby
Journal:  J Bone Miner Res       Date:  2002-07       Impact factor: 6.741

Review 10.  Interpretation and use of FRAX in clinical practice.

Authors:  J A Kanis; D Hans; C Cooper; S Baim; J P Bilezikian; N Binkley; J A Cauley; J E Compston; B Dawson-Hughes; G El-Hajj Fuleihan; H Johansson; W D Leslie; E M Lewiecki; M Luckey; A Oden; S E Papapoulos; C Poiana; R Rizzoli; D A Wahl; E V McCloskey
Journal:  Osteoporos Int       Date:  2011-07-21       Impact factor: 4.507

View more
  7 in total

1.  The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.

Authors:  Ratanapha Phuan-Udom; Nittaya Lektrakul; Wanruchada Katchamart
Journal:  Clin Rheumatol       Date:  2018-07-23       Impact factor: 2.980

2.  Comparison between frailty index of deficit accumulation and fracture risk assessment tool (FRAX) in prediction of risk of fractures.

Authors:  Guowei Li; Lehana Thabane; Alexandra Papaioannou; Jonathan D Adachi
Journal:  Bone       Date:  2015-04-25       Impact factor: 4.398

3.  FRAX fracture risk in women with a recent fracture of the distal forearm: agreement between assessments with and without bone mineral density and impact of measurement side in the individual patient.

Authors:  Emilie Lund Egsmose; Mette Birkvig; Thora Buhl; Ole Rintek Madsen
Journal:  Clin Rheumatol       Date:  2014-05-14       Impact factor: 2.980

Review 4.  The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.

Authors:  Elizabeth M Curtis; Rebecca J Moon; Nicholas C Harvey; Cyrus Cooper
Journal:  Bone       Date:  2017-01-22       Impact factor: 4.398

5.  Reprint of: The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.

Authors:  Elizabeth M Curtis; Rebecca J Moon; Nicholas C Harvey; Cyrus Cooper
Journal:  Int J Orthop Trauma Nurs       Date:  2017-04-26

Review 6.  State of the art in osteoporosis risk assessment and treatment.

Authors:  J Liu; E M Curtis; C Cooper; N C Harvey
Journal:  J Endocrinol Invest       Date:  2019-04-12       Impact factor: 4.256

7.  Evaluation of the effects of β1-selective beta-blockers on bone mineral density and fracture risk in postmenopausal women

Authors:  Betül Yavuz Keleş; Meltem Vural; Burcu Önder; Kadriye Öneş
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.